FDA has confirmed HPPI's clinical and regulatory pathway for SUBA BCCNS and provided further guidance for anticipated NDA submission
PR Newswire
TAMPA, Fla., Aug. 6, 2018
PR Newswire
TAMPA, Fla., Aug. 6, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey